Crossmark

mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels)

Crossref DOI link: https://doi.org/10.1016/j.gastre.2023.01.009

Published Print: 2023-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Riveiro-Barciela, Mar

Roade, Luisa

Martínez-Camprecios, Joan

Vidal-González, Judit

Rodríguez-Diez, Basilio

Perelló, Manel

Ortí, Guillermo

Robles-Alonso, Virginia

Berastegui, Cristina

Navarro, Jordi

Martínez-Valle, Fernando

Bilbao, Itxarone

Castells, Lluis

Ventura-Cots, Meritxell

Llaneras, Jordi

Rando-Segura, Ariadna

Forns, Xavier

Lens, Sabela

Prieto, Martín

García-Eliz, María

Imaz, Arkaitz

Rodríguez-Frías, Francisco

Buti, Maria

Esteban, Rafael
License Information

Text and Data Mining valid from 2023-12-01

stm-asf valid from 2023-12-01

stm-asf valid from 2023-12-01

stm-asf valid from 2023-12-01

stm-asf valid from 2023-12-01

stm-asf valid from 2023-12-01
More Information

This article is maintained by: Elsevier

Article Title: mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels)

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2023.01.009

Content Type: article

Copyright: © 2023 Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below